Next Article in Journal
Improved Pharmacokinetic Feasibilities of Mirabegron-1,2-Ethanedisulfonic Acid, Mirabegron-1,5-Naphthalenedisulfonic Acid, and Mirabegron-L-Pyroglutamic Acid as Co-Amorphous Dispersions in Rats and Mice
Next Article in Special Issue
Unveiling the Potential of Extracellular Vesicles as Biomarkers and Therapeutic Nanotools for Gastrointestinal Diseases
Previous Article in Journal
Antitumor Effects of Pegylated Zinc Protoporphyrin-Mediated Sonodynamic Therapy in Ovarian Cancer
Previous Article in Special Issue
Preparation of Nanoparticle-Loaded Extracellular Vesicles Using Direct Flow Filtration
 
 
Review

Article Versions Notes

Pharmaceutics 2023, 15(9), 2276; https://doi.org/10.3390/pharmaceutics15092276
Action Date Notes Link
article xml file uploaded 4 September 2023 08:54 CEST Original file -
article xml uploaded. 4 September 2023 08:54 CEST Update https://www.mdpi.com/1999-4923/15/9/2276/xml
article pdf uploaded. 4 September 2023 08:54 CEST Version of Record https://www.mdpi.com/1999-4923/15/9/2276/pdf
article html file updated 4 September 2023 08:55 CEST Original file https://www.mdpi.com/1999-4923/15/9/2276/html
Back to TopTop